Gamma-secretase inhibition lowers plasma triglyceride-rich lipoproteins by stabilizing the LDL receptor

Excess plasma triglycerides (TG) are a key component of obesity-induced metabolic syndrome. We have shown that γ-secretase inhibitor (GSI) treatment improves glucose tolerance due to inhibition of hepatic Notch signaling, but find additional, Notch-independent reduction of plasma TG-rich lipoprotein...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Metab
Main Authors: Kim, KyeongJin, Goldberg, Ira J., Graham, Mark J., Sundaram, Meenakshi, Bertaggia, Enrico, Lee, Samuel, Qiang, Li, Haeusler, Rebecca A., Metzger, Daniel, Chambon, Pierre, Yao, Zemin, Ginsberg, Henry N., Pajvani, Utpal B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884729/
https://ncbi.nlm.nih.gov/pubmed/29576536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2018.02.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados